DOJ will examine UnitedHealth’s Medicare billing practices: The Trump administration has made “waste, fraud, and abuse” a rallying cry. Now, we find out how serious they are about it.
HHS instructs CDC to shelve vaccine ads, including for the flu: RFK Jr. was at the helm of a decision to halt the CDC’s vaccine-focused advertisements—an early indicator of the steps he’s willing to take in his new role as HHS Secretary.
The Ozempic shortage is over: We explore how an FDA decision impacts compounded weight loss drug sellers like Hims & Hers and patients who are prescribed GLP-1s.
“Dr. AI” is the new “Dr. Google”: 60% of US consumers have used AI for health guidance. Healthcare marketers and providers should educate the public on responsible use of AI for medical purposes.
Hims & Hers moves into at-home testing: Its recent acquisition of a small lab testing company could have a big payoff.
Talkspace posts its first full year of profitability: But it’s not all rosy. It’s catching heat for sending teens’ data to social media platforms. Talkspace must be sure not to spoil its prosperity by damaging its reputation.
News and magazine apps have the highest engagement score in North America, with 29% of monthly active users coming back daily, according to a September 2024 Airship survey.
Docs are using AI more, and are more excited about its potential: But physicians want more regulatory oversight before they completely trust the tech. Recent workforce cuts at the FDA could make this difficult to achieve.
Another full-body medical scan startup raises its Series B: Even though the value of full-body scans is up for debate in medical communities, it’s hard to see the hype fading anytime soon.
RFK to lead Trump’s Make America Healthy Again commission: Trump’s executive order outlines policies and actions that could impact medication access for children, how quickly drugs get to market, and how federal health agencies conduct research.
How RFK Jr.'s HHS Secretary confirmation could impact pharma: Brands and marketers may need to recalibrate strategies for vaccine messaging, GLP-1 medication access, and drug advertising.
CVS gives investors hope for a better 2025: The key to satisfying Wall Street is to stabilize Aetna. Here’s how CVS plans to make it happen.
Apple launches new health study: Its experience conducting health studies for product development positions the company well to roll out new health-tracking features and capabilities.
Everyone is talking about Hims’ Super Bowl weight loss drug ad: The reaction has been largely negative. We examine why it’s a gamble that will likely pay off for Hims.
Doctors take issue with NYU Langone Health’s Super Bowl ad: They’re largely questioning the not-for-profit’s choice to pay $8M+ for the ad. We explore why health systems would be better off advertising in local markets than national TV events.
Pediatric care provider Summer Health acquires Gen Z-focused virtual care company: Summer has an opportunity to establish rapport and build trust with young patients who don’t have much experience with the conventional healthcare system.
Key stat: 19% of US adults play team sports, up from 11% in 2020, according to CivicScience, signaling that people aren’t only watching sports, they’re participating as well.
Oregon bill seeks to ban AI nurses: If passed, the bill could provide a framework for other states as they work to regulate the use of AI in healthcare settings.
Parents sue Walgreens, OptumRx over son’s death: They allege that a sudden price hike of his asthma medication made it unaffordable. The lawsuit will put more pressure on regulators to lower medication costs and improve drug pricing transparency.
Pharma giants report mixed earnings for GLP-1s in Q4: Supply challenges and weight loss drug market competition could pose the biggest threats to Novo and Lilly in 2025.